Sangamo Therapeutics Inc at Jefferies Gene Therapy/Editing Summit Transcript
Okay, my name is Maury Raycroft and I am one of the biotech analysts at Jefferies. And I'd like to welcome Sandy Macrae, the CEO of Sangamo Therapeutics. Thanks for joining us today, Sandy.
It is a pleasure to be here.
Questions & Answers
Great. And so we are going to do a fireside chat. Maybe to start it off, if you can give an overview of Sangamo's pipeline for people that are new to the story, and what are important catalysts for the next 6 to 12 months.
So Sangamo is a fascinating Company. We are the genomic medicine company. We are known for our zinc fingers and our editing capabilities and editing is core of what we do. But if you can do editing, you can do a range of different things through our knowledge of genomic manipulation and AAVs and taking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
